Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress
Author:
Publisher
Elsevier BV
Reference40 articles.
1. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis;Kumar;Adv. Drug Deliv. Rev.,2021
2. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice;Yang;Phytother Res.,2019
3. Diabetes mellitus and cardiovascular diseases: nutraceutical interventions related to caloric restriction;Senesi;Int. J. Mol. Sci.,2021
4. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment;Smith;Nat. Rev. Endocrinol.,2011
5. Jujuboside A inhibits oxidative stress damage and enhances immunomodulatory capacity of human umbilical cord mesenchymal stem cells through up-regulating Ido expression;Chen;Chin. J. Nat. Med.,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3